What are the NCCN guidelines on primary treatment of neuroendocrine tumors (NETs) of the GI tract, lung, and thymus?

Updated: Dec 23, 2018
  • Author: Evan S Ong, MD, MS; more...
  • Print


NCCN guidelines recommend resection as the primary treatment for most carcinoid tumors of the gastrointestinal (GI) tract, lung, and thymus. Specific recommendations vary by tumor subtype. However, for neuroendocrine tumors at any site, cholecystectomy is recommended during surgical resection if treatment with a somatostatin analog (ie, octreotide, lanreotide) is planned, due to the increased rate of biliary problems associated with long-term use of these agents. [7]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!